Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population
| Status: | Recruiting |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 3/15/2019 |
| Start Date: | April 24, 2018 |
| End Date: | December 1, 2021 |
| Contact: | Nicole T Shen, MD |
| Email: | nts9004@nyp.org |
| Phone: | 3146095911 |
This is a pilot study examining whether an evidence-based recovery support smartphone
application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can
decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver
disease (ALD).
application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can
decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver
disease (ALD).
A-CHESS is a smartphone application developed by the University of Wisconsin-Madison based on
self-determination theory, with a previous randomized clinical trial showing that use of the
app resulted in significantly fewer risky drinking days in patients leaving treatment for
alcohol-use disorders. The application is downloaded to the participant's smartphone, and
provides ongoing access to peer support and educational materials, monitoring of the risk of
relapse, and delivery of reminders and encouragements to the patient. The application also
has a survey platform to assess and reassess the participants' most recent alcohol
consumption, quality of life, and experience using the application. We anticipate that use of
the A-CHESS app will result in decreased drinking and improved abstinence, identifying a
potential intervention to offer patients with ALD to improve their mortality, liver disease,
and likelihood of liver transplant candidacy status.
self-determination theory, with a previous randomized clinical trial showing that use of the
app resulted in significantly fewer risky drinking days in patients leaving treatment for
alcohol-use disorders. The application is downloaded to the participant's smartphone, and
provides ongoing access to peer support and educational materials, monitoring of the risk of
relapse, and delivery of reminders and encouragements to the patient. The application also
has a survey platform to assess and reassess the participants' most recent alcohol
consumption, quality of life, and experience using the application. We anticipate that use of
the A-CHESS app will result in decreased drinking and improved abstinence, identifying a
potential intervention to offer patients with ALD to improve their mortality, liver disease,
and likelihood of liver transplant candidacy status.
Inclusion Criteria:
- Alcoholic liver disease
- Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center
- English speaking
- Access to a smartphone
Exclusion Criteria:
- Unable to consent
- Primary language other than English
- No access to a smartphone
We found this trial at
1
site
630 West 168th Street
New York, New York 10021
New York, New York 10021
Phone: 314-609-5911
Click here to add this to my saved trials
